MiMedx Stock Forward View - Price Action Indicator
| MDXG Stock | USD 5.14 0.01 0.19% |
MiMedx Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of MiMedx's historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of MiMedx's share price is below 30 as of 29th of January 2026. This indicates that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling MiMedx Group, making its price go up or down. Momentum 28
Sell Stretched
Oversold | Overbought |
Using MiMedx hype-based prediction, you can estimate the value of MiMedx Group from the perspective of MiMedx response to recently generated media hype and the effects of current headlines on its competitors.
MiMedx after-hype prediction price | USD 5.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections. MiMedx Additional Predictive Modules
Most predictive techniques to examine MiMedx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MiMedx using various technical indicators. When you analyze MiMedx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.12) | 0.03 |
| Check MiMedx Volatility | Backtest MiMedx | Information Ratio |
MiMedx Trading Date Momentum
| On January 29 2026 MiMedx Group was traded for 5.14 at the closing time. The top price for the day was 5.16 and the lowest listed price was 5.05 . The trading volume for the day was 583.6 K. The trading history from January 29, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.19% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare MiMedx to competition |
Other Forecasting Options for MiMedx
For every potential investor in MiMedx, whether a beginner or expert, MiMedx's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MiMedx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MiMedx. Basic forecasting techniques help filter out the noise by identifying MiMedx's price trends.MiMedx Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MiMedx stock to make a market-neutral strategy. Peer analysis of MiMedx could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MiMedx Market Strength Events
Market strength indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By undertsting and applying MiMedx stock market strength indicators, traders can identify MiMedx Group entry and exit signals to maximize returns.
MiMedx Risk Indicators
The analysis of MiMedx's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MiMedx's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mimedx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.97 | |||
| Standard Deviation | 2.48 | |||
| Variance | 6.16 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MiMedx
The number of cover stories for MiMedx depends on current market conditions and MiMedx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MiMedx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MiMedx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MiMedx Short Properties
MiMedx's future price predictability will typically decrease when MiMedx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MiMedx Group often depends not only on the future outlook of the potential MiMedx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MiMedx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 149 M | |
| Cash And Short Term Investments | 104.4 M |
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Can Stock industry sustain growth momentum? Does MiMedx have expansion opportunities? Factors like these will boost the valuation of MiMedx. Expected growth trajectory for MiMedx significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating MiMedx demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that MiMedx's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MiMedx represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MiMedx's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.